Zoetis ZTS
NYSE ZTS
$73.31 -0.25 (-0.34%)
As of: Sep 9, 2026 · 3:59 PM EDT

Zoetis (ZTS) Change in Receivables (2014 - 2026)

Zoetis' (ZTS) quarterly Change in Receivables came in at $66.0 million in Q2 2026, down 37.74% year-over-year from $106.0 million in Q2 2025, and down 37.74% quarter-over-quarter from $106.0 million in Q1 2026.

Analysis

Zoetis (ZTS) Change in Receivables (2014 - 2026) Analysis & Trends

Zoetis (ZTS) has reported Change in Receivables for 13 consecutive years, with $66.0 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Change in Receivables fell 37.74% year-over-year to $66.0 million in Q2 2026; TTM through Jun 2026 was $256.0 million, a 153.47% increase from a year earlier, with the FY2025 full-year figure at $236.0 million, up 286.89% from the prior year.
  • Change in Receivables was $66.0 million for Q2 2026 at Zoetis, down from $106.0 million in the prior quarter.
  • Over five years, Change in Receivables peaked at $143.0 million in Q2 2023 and troughed at -$73.0 million in Q4 2024.
  • A 5-year average of $39.3 million and a median of $47.0 million in 2023 frame the typical range for Change in Receivables.
  • Across the five-year window, Change in Receivables plunged 933.33% in 2022 and jumped 283.33% in 2025, its largest moves.
  • Over 5 years, Change in Receivables stood at $17.0 million in 2022, then jumped by 182.35% to $48.0 million in 2023, then sank by 252.08% to -$73.0 million in 2024, then surged by 171.23% to $52.0 million in 2025, then grew by 26.92% to $66.0 million in 2026.
  • The last three Change in Receivables figures came in at $66.0 million (Q2 2026), $106.0 million (Q1 2026), and $52.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Idexx Laboratories 40.69 Bn 40.49 Bn 779.09 Mn 26.04 Mn
2 Zoetis 30.63 Bn 28.95 Bn 1.05 Bn 66.00 Mn
3 Elanco Animal Health 11.77 Bn 11.24 Bn 798.00 Mn -
4 Phibro Animal Health 1.49 Bn 1.41 Bn 134.40 Mn 16.42 Mn
5 Immucell 90.19 Mn 81.33 Mn 2.44 Mn -
6 Zhengye Biotechnology Holding 76.23 Mn 69.14 Mn - -
7 Global Innovative Platforms 24.88 Mn 24.63 Mn - -3,300.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 66.00 Mn
Mar 31, 2026 106.00 Mn
Dec 31, 2025 52.00 Mn
Sep 30, 2025 32.00 Mn
Jun 30, 2025 106.00 Mn
Mar 31, 2025 46.00 Mn
Dec 31, 2024 -73.00 Mn
Sep 30, 2024 22.00 Mn
Jun 30, 2024 100.00 Mn
Mar 31, 2024 12.00 Mn
Dec 31, 2023 48.00 Mn
Sep 30, 2023 -62.00 Mn
Jun 30, 2023 143.00 Mn
Mar 31, 2023 -27.00 Mn
Dec 31, 2022 17.00 Mn
Sep 30, 2022 -62.00 Mn
Jun 30, 2022 80.00 Mn
Mar 31, 2022 102.00 Mn
Dec 31, 2021 12.00 Mn
Sep 30, 2021 -6.00 Mn